VentiRx Pharmaceuticals Secures $25,000,000 Series A Financing

  • Feed Type
  • Date
    1/12/2010
  • Company Name
    VentiRx Pharmaceuticals
  • Mailing Address
    12651 High Bluff Drive San Diego, CA 92130
  • Company Description
    VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.
  • Website
    http://www.ventirx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Domain Associates

Next Post

Related Topics

Related Posts

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.